James Morris Lewis is a Birmingham, Alabama based male Ophthalmologist who is specialized in Ophthalmology. Active license number of James Morris Lewis is 9233 for Ophthalmology in Alabama. James Morris Lewis is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
James Morris Lewis speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Male
Practice Address:
1704 5th Ave No, Birmingham, Alabama, 35203
Phone:
205-326-3800
Fax:
205-326-3021
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1821054511
NPI Enumeration Date:
22 Apr, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for James Morris Lewis are as mentioned below.
License Number
Specialization
State
Status
9233
Ophthalmology
Alabama
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1704 5th Ave No, Birmingham, Alabama
Zip:
35203
Phone Number:
205-326-3800
Fax Number:
205-326-3021
Patients can reach James Morris Lewis at 1704 5th Ave No, Birmingham, Alabama or can call to book an appointment on 205-326-3800. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.